Search Results - amy trauernicht

1 Results Sort By:
A method to better predict the likelihood that endocrine therapy alone after surgical intervention will be sufficient to treat patients with estrogen-receptor-positive breast cancer
The University of Texas Health Science Center at San Antonio seeks to partner with a diagnostic products company to develop and commercialize a clinical diagnostic with the potential to determine if a patient with estrogen receptor (ER) positive breast cancer is suitable for treatment with endocrine therapy (e.g., tamoxifen and/or the aromatase inh...
Published: 2/7/2013   |   Inventor(s): Amy Trauernicht, Thomas Boyer
Keywords(s): Biologics, Drugs
Category(s): Diagnostics